SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001437749-22-021841
Filing Date
2022-09-02
Accepted
2022-09-02 21:06:11
Documents
1
Period of Report
2022-08-31

Document Format Files

Seq Description Document Type Size
1 FORM 4 rdgdoc.html 4  
1 FORM 4 rdgdoc.xml 4 7129
  Complete submission text file 0001437749-22-021841.txt   8855
Mailing Address 300 EAST MAIN STREET SUITE 201 CHARLOTTESVILLE VA 22902
Business Address 300 EAST MAIN STREET SUITE 201 CHARLOTTESVILLE VA 22902 (434) 220-0718
Diffusion Pharmaceuticals Inc. (Issuer) CIK: 0001053691 (see all company filings)

IRS No.: 300645032 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address DIFFUSION PHARMACEUTICALS INC. 1317 CARLTON AVENUE, SUITE 200 CHARLOTTESVILLE VA 22902
Business Address
Hollingsworth Jane H (Reporting) CIK: 0001297141 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37942 | Film No.: 221226671